832 results on '"Iacoviello Massimo"'
Search Results
152. Remote Monitoring for Implantable Defibrillators: A Nationwide Survey in Italy
153. Continuous flow left ventricular assist devices do not worsen endothelial function in subjects with chronic heart failure: a pilot study
154. Biomarkers in Cardiorenal Syndrome
155. The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic
156. Recent advances in pharmacological treatment of heart failure
157. Multivessel spontaneous coronary artery dissection and Crohn's disease
158. Eligibility of outpatients with chronic heart failure for sodium–glucose co‐transporter‐2 inhibitors
159. The 212A Variant of the APJ Receptor Gene for the Endogenous Inotrope Apelin is Associated With Slower Heart Failure Progression in Idiopathic Dilated Cardiomyopathy
160. Prevalence, clinical impact and costs of hyperkalaemia: Special focus on heart failure
161. Cardiac contractility modulation in left ventricular systolic dysfunction: trick or treat?
162. Heart failure in frail elderly resident in a nurse house: prognostic significance of a multimarker approach
163. Sacubitril/Valsartan and Cognitive Outcomes in Heart Failure With Reduced Ejection: A New Pharmacological Indication?
164. Independent Role of Left Ventricular Global Longitudinal Strain in Predicting Prognosis of Chronic Heart Failure Patients
165. Remodelling is inversely proportional to left ventricular dimensions in a real-life population of patients with chronic heart failure after therapy with sacubitril/valsartan.
166. Reverse cardiac remodeling after fluid balance optimization in patients with end-stage renal disease.
167. Epidemiology of cardiomyopathies: essential context knowledge for a tailored clinical work-up.
168. Could Dilated Cardiomyopathy Alter the Peripheral Microcirculation and Blood Rheology?
169. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction
170. Altered two-dimensional strain measures of the right ventricle in patients with Brugada syndrome and arrhythmogenic right ventricular dysplasia/cardiomyopathy
171. Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
172. Epidemiology of cardiomyopathies: essential context knowledge for a tailored clinical work-up
173. Coronary thrombosis due to heparin‐induced thrombocytopenia after percutaneous coronary intervention: Easy to miss, uneasy to prevent
174. The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
175. Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
176. The PARAGON-HF Trial
177. Congestive Heart Failure and Thyroid Dysfunction: The Role of the Low T3 Syndrome and Therapeutic Aspects
178. Would You Prescribe Mobile Health Apps for Heart Failure Self-care? An Integrated Review of Commercially Available Mobile Technology for Heart Failure Patients
179. Right Ventricular Function in Chronic Heart Failure: From the Diagnosis to the Therapeutic Approach
180. Thyroid Disorders and Prognosis in Chronic Heart Failure: A Long-Term Follow-Up Study
181. MULTIPLE HORMONAL AND METABOLIC DEFICIENCY SYNDROME REDUCES SURVIVAL IN CHRONIC HEART FAILURE: THE TOSCA REGISTRY
182. Metformin: Up to Date
183. Nitrate-Potentiated Head-Up Tilt Testing in Older Patients: Outcomes, Hemodynamic Responses and Prodrome Recognition
184. Independent role of reduced arterial baroreflex sensitivity during head-up tilt testing in predicting vasovagal syncope recurrence
185. Prevalence, timing, and haemodynamic correlates of prodromes in patients with vasovagal syncope induced by head-up tilt test
186. Impaired arterial baroreflex function before nitrate-induced vasovagal syncope during head-up tilt test
187. Association of β-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy
188. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure
189. The PONTE (PDTA FOR INTEGRATED FOLLOW-UP TERRITORY HOSPITAL OF THE PATIENT WITH CARDIAC HEARTFAILURE) (BRIDGE) Heart Failure project: increased adherence to guideline-recommended therapies through web-based shared clinical database
190. Prognostic role of neoplastic markers in Takotsubo syndrome.
191. L'educazione terapeutica del paziente scompensato.
192. Local peribulbar anesthesia before glaucoma filtering surgery in a patient with Brugada syndrome
193. Mineralcorticoid Receptor Antagonist Withdrawal for Hyperkalemia and Mortality in Patients with Heart Failure
194. Multiparametric approach to congestion for predicting long-term survival in heart failure
195. Valutazione di un approccio basato sul dosaggio di multipli biomarcatori nella diagnosi di scompenso cardiaco in soggetti in età geriatrica
196. Serum biochemical determinants of peripheral congestion assessed by bioimpedance vector analysis in acute heart failure
197. New Frontiers in the Therapeutic Approach of Patients with Cardiovascular and Endocrine Diseases
198. Association between high Gal-3 serum levels and worsening of renal function in chronic heart failure outpatients
199. Bioimpedance vector analysis predicts hospital length of stay in acute heart failure
200. Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.